Drug Companies Discover Clever Loophole to Avoid Listing Side Effects in Direct-to-Consumer Advertising

Thursday, February 05, 2009 by: David Gutierrez, staff writer
Tags: drug advertising, health news, Natural News

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
GMO crops totally banned in Russia... powerful nation blocks Monsanto's agricultural imperialism and mass poisoning of the population
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Pepsi drops aspartame from diet soda as consumers reject toxic sweetener
Bride of Frankenfood: Hillary Clinton pushes GMO agenda... hires Monsanto lobbyist... takes huge dollars from Monsanto
STATINS RED ALERT: Widely prescribed drugs act as cellular poisons that accelerate aging... deactivate DNA repair... promote diabetes, muscle fatigue and memory loss
Wild eyes and bowl cuts: Why do mass shooters always share the same hair styles and crazed zombie stares?
Mind control through emotional domination: How we're all being manipulated by the "crisis of the NOW"
(NaturalNews) Pharmaceutical companies have discovered a way to circumvent federal rules that require the listing of side effects in any direct-to-consumer ads: running ads that never mention specific drugs by name but merely direct consumers to a Web site that promotes the company's products.

"With unbranded ads, you don't have the 'fair balance' requirement," said Rich Gagnon of the DraftFCB ad agency, which represents several drug companies. "Imagine paying millions to run that ad campaign, and having to use up 30 seconds to list all the problems."

A recent one-minute ad for Eli Lilly's osteoporosis drug Evista spent 25 seconds listing potential side effects, including blood clots and "dying from stroke."

One of the most notable recent "unbranded" ads is Pfizer's My Time to Quit ad, aired during the Beijing Olympics. The ad features a middle-aged woman discussing her smoking problem, discusses options available for those who wish to quit, then encourages viewers to visit mytimetoquit.com. The Web site includes a link to the site for Pfizer's anti-smoking drug Chantix, which lists the drug's side effects.

The My Time to Quit ad was originally aired as part of the company's campaign to familiarize users with the drug after its 2006 introduction, and was then retired. But after a number of studies linked the drug to drowsiness, traffic accidents and suicide, the company reintroduced the older ad.

Another successful unbranded ad has been one by Sanofi-Aventis, maker of the insomnia drug Ambien. A 15-second ad directs viewers to silenceyourrooster.com, which contains information about Ambien. During the ad's first week on the air, it generated 400,000 hits to the Web site.

Direct-to-consumer drug ads have recently been the subject of congressional investigations, leading Bob Ehrlich of the direct-to-consumer organization DTC Perspectives to speculate that the new ads could ultimately draw the same negative attention.

"There's a risk they could rouse congressional ire over cute commercials that don't emphasize medicine," Ehrlich said.

Sources for this story include: blogs.wsj.com; www.commercialalert.org.

Follow real-time breaking news headlines on
Drug advertising at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.